Akèy › Enfeksyon Viral › Kalifòni
Etid klinik pou Enfeksyon Viral nan Kalifòni
11 etid pou Enfeksyon Viral ap chèche patisipan nan sit nan Kalifòni.
Vil nan Kalifòni
Tèks ofisyèl etid la (Anglè)
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- Research Site, Fresno
- Research Site, Newport Beach
- Research Site, Torrance
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT05624450A Study of S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial Virus (RSV) Who Are at High Risk of Progression to Severe Disease
- LA Universal Research Center, Inc., Los Angeles
- Central Valley Research, Modesto
- Med Partnes, Inc - Elligo- PPDS, Toluca Lake
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT07214571A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
- National Institute of Clinical Research - Bakersfield, Bakersfield
- Velocity Clinical Research, Huntington Park, Huntington Park
- 310 Clinical Research, Inglewood
- ak 9 plis
Ap rekriteFaz 3
Laj 12 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06679140A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
- Hope Clinical Research, Inc., Canoga Park
- Amicis Research Center - Granada Hills, Granada Hills
- Jacobs Medical Center at UC San Diego Health, La Jolla
- ak 4 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07013474Study of AHB-137 in Chronic Hepatitis B (CHB) Participants in North America and Europe Regions
- Stanford University, Palo Alto
Ap rekriteFaz 2
Laj 18 a 65 · Tout sèks · Mizajou Sep 24, 2026 · NCT07654283A Phase 1/2A, Randomized Study of a T Follicular Helper (TFH)-Targeting Genetic Vaccine Strategy Designed to Induce Broad, Durable Immune Responses
- UCLA Westwood, Los Angeles
- UCSF Community and Clinical Research Center, San Francisco
Ap rekriteFaz 1/2Volontè an sante akeyi
Laj 40 a 64 · Tout sèks · Mizajou Aug 18, 2026 · NCT06810934A Study to Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years of Age
- Diablo Clinical Research, LLC dba Flourish Research, Walnut Creek
Ap rekriteFaz 4Volontè an sante akeyi
Laj 18 a 64 · Tout sèks · Mizajou Aug 7, 2026 · NCT07730450Treatment of Refractory BK Infections With Related Donor BK Specific Cytotoxic T-cells (CTLs)
- University of California San Francisco, San Francisco
Ap rekriteFaz 1/2
1 Month – 79 Years · Tout sèks · Mizajou Apr 15, 2026 · NCT04197596Microbial Cell-free Metagenomic Sequencing for Suspected Infections in Adult Immunocompromised Outpatients
- University of California San Francisco, San Francisco
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jan 30, 2026 · NCT07110636Effects of Mouthrinse on the Microbiome of the Oral Cavity and GI Tract
- Beckman Laser Institute and Medical Clinic, Irvine
Ap rekriteVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Dec 17, 2025 · NCT05603650Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions
- Southern California Hospital at Culver City / Southern California Hospital at Hollywood / Multiple US-based Sub-Investigator Sites, Culver City
Ap rekriteFaz 1/2Volontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Apr 29, 2022 · NCT04684602Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.